Pharmaceutical

Vistagen obtains Canadian Notice of Allowance for AV-101 patent

Vistagen has received a Canadian Notice of Allowance for patent that is related to the use of AV-101 in Parkinson's disease (PD) patients.

Jul 15, 2023 - 20:00
Vistagen obtains Canadian Notice of Allowance for AV-101 patent
Vistagen has received a Canadian Notice of Allowance for patent that is related to the use of AV-101 in Parkinson's disease (PD) patients.
Read the original article

Tags:

Previous Article

Theseus terminates its GI cancer drug development programme

Next Article

Gilead, CHAI and Penta to enhance HIV treatment for children

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: STAT+: An overlooked way to make participants in clinical trials look more like America

Opinion: STAT+: An overlooked way to make participants ...

May 27, 2023

Opinion: Your health insurance may not be as good your state requires — and it’s perfectly legal

Opinion: Your health insurance may not be as good your ...

Jun 10, 2023

Janssen submits sBLA to FDA for NSCLC combination therapy

Janssen submits sBLA to FDA for NSCLC combination therapy

Aug 28, 2023